title: Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
authors.affiliation: Department of Infectious Diseases, Hospital Rothschild, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Lallemand
authors.forename: N
authors.initials: N
authors.lastname: Adda
authors.forename: V
authors.initials: V
authors.lastname: Schneider
authors.forename: C
authors.initials: C
authors.lastname: Jacomet
authors.forename: Y
authors.initials: Y
authors.lastname: Salhi
authors.forename: W
authors.initials: W
authors.lastname: Rozenbaum
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D009154:Mutation; D019438:Ritonavir / Q000627:therapeutic use*; D019258:Saquinavir / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019469:Indinavir; D016333:HIV Protease; D019258:Saquinavir; D019438:Ritonavir